Pixels & Pills

Entries Tagged as 'Pharmaceutical industry'

4 Things Pharma Marketing Can Learn from Other Industries

September 2nd, 2010 · No Comments · Opinion, Trends

By Guy Mastrion (@gmastrion)
Across all industries, people are using new technologies, tactics and communication mediums to connect with customers and accelerate business momentum. What qualities do other industries possess that can be beneficial to pharma?
Retail – Think Outside the Store
Retail has broken free from brick-and-mortar establishments and catalog shopping to include social media, online and [...]

[Read more →]

Tags:·················

Can Pharma Have an Old Spice Guy? Pharma’s Problems With Personality

July 16th, 2010 · 2 Comments · News, Opinion

By Kimberly Reyes (@CommDuCoeur)
It’s no shock that on Monday, February 8, 2010, people were buzzing about the Superbowl game the day before.  What was a surprise is that they weren’t necessarily talking about the New Orleans Saints first Superbowl win against the Indianapolis Colts – they were most likely gushing over the Weiden + Kennedy [...]

[Read more →]

Tags:··················

Productivity Applications for Pharma Sales

June 29th, 2010 · No Comments · Opinion

This post is part of a week-long series identifying the challenges facing Pharma sales, and determining digital solutions to deal with these obstacles.
By Bob Mason (@BobMasonPalio)
With ever-shrinking headcount and budget figures, sales and marketing teams are under more pressure than ever to make sure that their sales forces are performing optimally.
There are about 100,000 pharmaceutical [...]

[Read more →]

Tags:···········

DTC: Death to Commercials

June 25th, 2010 · 4 Comments · Opinion

By Guy Mastrion (@gmastrion)
I’m going to speak heresy as an advertising creative director, specifically one working in healthcare. I’m coming to the belief that the FDA should put an end to branded TV commercials for pharma products.
Why?
Because I believe we’ve all been lulled into a healthcare coma by unimaginative, often nonsensical commercials attempting to communicate [...]

[Read more →]

Tags:·············

Why Healthcare Reform Isn’t Just About Insurance

June 7th, 2010 · 2 Comments · Opinion

(Photo by Win McNamee/Getty Images North America)
By Kimberly Reyes (@CommDuCoeur)
On March 23, 2010, President Obama signed his controversial Healthcare Reform Bill into law, with the objective of making healthcare more affordable and expanding coverage to the 32 million Americans that are currently uninsured, including self-employed individuals and low-income families.
Groups such as Physicians for Reform [...]

[Read more →]

Tags:············

How Do You Market Pharma Where DTC is Illegal?

June 2nd, 2010 · 5 Comments · Opinion

This post will continue our week-long theme of “Pharma Without Borders,” which inspects how Pharma companies engage with doctors and patients overseas.
By Russ Ward (@russcward)
Sometimes we forget that DTC is unusual and new in the global pharmaceutical market. But direct-to-consumer (DTC) advertising of prescription drugs is illegal everywhere in the world with two exceptions. The [...]

[Read more →]

Tags:···········

Interview with AstraZeneca’s Earl Whipple

May 17th, 2010 · 13 Comments · Uncategorized

Earl D. Whipple is the Senior Director of Business Communications and Digital Media for AstraZeneca.  In an effort to drive online visibility and digital engagement for one of the world’s leading biopharmaceutical companies, Earl and his team launched AstraZeneca’s first company blog and Facebook community.  Today, Pixels & Pills talks to Earl about Pharma’s obligation [...]

[Read more →]

Tags:···············

Following Up With Steve Woodruff of Impactiviti

May 14th, 2010 · No Comments · Opinion

This post wraps up our week-long discussion around the topic “What Would the Government Regulate?”
By Jason Brandt (@Jasondmg3)
Last month, Pixels & Pills’ Jennifer Abelson interviewed Steve Woodruff of Impactiviti at the ePharma Summit.
Apart from how utterly TV-presenter smooth both of their voices are – we’re lucky they got into pharma before they were snapped up [...]

[Read more →]

Tags:·············

Live-ish from the Social Communications & Healthcare: Case Studies & Roundtables

May 11th, 2010 · No Comments · News

Pixels & Pills is in the Graduate Center of The City University of New York in midtown Manhattan, New York City bringing you all the action from BDI’s Social Communications & Healthcare: Case Studies & Roundtables.  Jason Brandt and Carl Turner talk to the speakers and other prominent faces in Pharma about the issues [...]

[Read more →]

Tags:······

Why the Core Visual Aid is DEAD…Vive la IVA!

May 10th, 2010 · No Comments · Opinion

By Paul Harrington
R.I.P., CVA.
Friends, Romans, and countrymen, lend me your ears: I come not to praise the CVA, but to bury it.
The CVA – or Core Visual Aid – the most commonly used sales tool in the armamentarium of pharmaceutical sales is dead, dead, dead. Certainly, for decades it had served us well: it gave [...]

[Read more →]

Tags:··········